Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment.

MLA

Su, Jun-Hui, et al. “Synkinesis in Primary and Postparalytic Hemifacial Spasm: Clinical Features and Therapeutic Outcomes of Botulinum Toxin A Treatment.” Toxicon : Official Journal of the International Society on Toxinology, vol. 184, Sept. 2020, pp. 122–26. EBSCOhost, https://doi.org/10.1016/j.toxicon.2020.06.004.

APA

Su, J.-H., Yang, M.-N., Teng, F., Zhang, X.-L., Pan, Y.-G., Hu, Y., Xiao, L.-B., Pan, L.-Z., Li, L.-X., & Jin, L.-J. (2020). Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment. Toxicon : Official Journal of the International Society on Toxinology, 184, 122–126. https://doi.org/10.1016/j.toxicon.2020.06.004

Chicago

Su, Jun-Hui, Ming-Na Yang, Fei Teng, Xiao-Long Zhang, You-Gui Pan, Yue Hu, Li-Bin Xiao, Li-Zhen Pan, Li-Xi Li, and Ling-Jing Jin. 2020. “Synkinesis in Primary and Postparalytic Hemifacial Spasm: Clinical Features and Therapeutic Outcomes of Botulinum Toxin A Treatment.” Toxicon : Official Journal of the International Society on Toxinology 184 (September): 122–26. doi:10.1016/j.toxicon.2020.06.004.